Li Hong, Director of the Pharmaceutical Division of the Consumer Products Industry Division of the Ministry of Industry and Information Technology, told reporters recently that the "12th Five-Year Plan" for the " biological industry " is currently awaiting the final discussion of the State Council and will be announced after the discussion. "Planning" predicts that the output value of the bio-industry will double by the end of the "Twelfth Five-Year Plan" period, and related industries will usher in a period of sustained high growth.
Li Hong said that "Planning" expects the output value of the bio-industry will reach 3.6 trillion by 2015, more than double the 2011 output value of 1.5 trillion yuan. According to the "Twelfth Five-Year Plan for Biotechnology Development" issued by the Ministry of Science and Technology, biomedicine, biomedical engineering, bio-agriculture, biomass energy, bio-manufacturing, bio-environmental protection and bio-services will be the focus of the development of the bio-industry. .
It is understood that in the "Eleventh Five-Year Plan", vaccines, diagnostic reagents, innovative drugs, and biomedical engineering have been given special support as key supports and a number of supporting policies have been issued. In the new bio-industry planning, in addition to the continuation and expansion of the original support specialties, it will also strengthen the support for innovative pharmaceuticals such as innovative vaccines, monoclonal antibodies, and genetic engineering drugs. These fields will be obtained in the future. More tax incentives, government support funds and technical support.
At present, the growth rate of the domestic diagnostic reagent industry has taken a leading position in the world. Under the trend of promoting early diagnosis and early detection of diseases, the vaccine industry is expected to achieve rapid development. Genetic engineering drugs have many features that are difficult to replace because of their many chemical drugs. In particular, recombinant protein drugs overcome the disadvantages of biologically extracted protein drugs with many impurities and unstable quality control, and they will receive strong support in the future.
At the same time, Li Hong pointed out that uncertainties in the future development of the bio-industry are mainly due to the current accelerated medical payment reform and the increasingly stringent trend of controlling health expenditures, and that the output value of the bio-industries should continue to be realized during the “Twelfth Five-Year Plan†period. There are many challenges to doubling.
Zhang Zongjiu, director of the Medical Supervision Service Department of the Ministry of Health, pointed out that according to the statistics of the World Health Organization, currently one third of patients worldwide have died of irrational drug use, and irrational drug use not only reduces the healing effect, but also brings a lot of unreasonable health costs. In the future, we must continue to strictly administer unreasonable medication. Some analysts said that many of the above areas are directly related to the bio-industry. The future of the bio-industry to cope with changes still requires corporate thinking.
It is reported that the Ministry of Industry and Information Technology has jointly issued relevant measures for the development of biopharmaceutical engineering products and protein medicines and vaccines with related ministries and commissions, and supports research and development in related fields. However, due to the requirements for applying for projects, phase III clinical testing must be completed. Therefore, the projects that currently meet the requirements are not many. "In the future, we must consider the measures to effectively support the development of the industry," said Li Hong.
Here you can find the related products in Face Masks, we are professional manufacturer of Face Masks,Medical Face Masks,Ear Loop Face Masks,Medical Grade Face Masks. We focused on international export product development, production and sales. We have improved quality control processes of Medical Face Masks to ensure each export qualified product.
If you want to know more about the products in Medical Face Masks, please click the product details to view parameters, models, pictures, prices and other information about Face Masks,Medical Face Masks,Ear Loop Face Masks,Medical Grade Face Masks.
Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Medical Face Masks!
Dust Mask,3 Layer Dust Mask,Face Mask Medical,Eco-Friendly Face Mask
BIQIAO MEDICAL TECHNOLOGY(HENAN) CO.,LTD , https://www.medical-technology.net